🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase II trial compares the effect of adding radiation therapy to the ...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-10-18
Trial ID
NCT06350162
Treatments Being Tested
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
A total of 100 adult volunteers of both sexes will be enrolled in the proje...
Status
Recruiting
Location
Oral Surgery Department Wroclaw Medical University
Start Date
2025-07-01
Trial ID
NCT07012915
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384